Raloxifene Hydrochloride

  (ra-LOK-sih-feen HY-droh-KLOR-ide)

This page contains brief information about raloxifene hydrochloride and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s):		Evista
		Keoxifene
FDA Approved:		Yes

FDA Approval for Raloxifene Hydrochloride

Raloxifene hydrochloride is approved to prevent:

• Breast cancer. It is used to decrease the chance of invasive breast cancer in postmenopausal women who have a high risk for developing the disease or who have osteoporosis.

Raloxifene hydrochloride is also approved to prevent and treat:

• Osteoporosis in postmenopausal women.

Raloxifene hydrochloride is also being studied in the treatment of other types of cancer.

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

MedlinePlus Information on Raloxifene Hydrochloride - A lay language summary of important information about this drug that may include the following:

• warnings about this drug,
• what this drug is used for and how it is used,
• what you should tell your doctor before using this drug,
• what you should know about this drug before using it,
• other drugs that may interact with this drug, and
• possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Hormone Therapy for Breast Cancer - Information about the use of this drug to prevent and treat cancer.

Clinical Trial Results: Tool Weighs Benefits, Risks of Raloxifene or Tamoxifen to Prevent Breast Cancer - Important clinical trial results for this drug, background information, and how the trial was done.

Results of the Study of Tamoxifen and Raloxifene (STAR) Released: Osteoporosis Drug Raloxifene Shown to be as Effective as Tamoxifen in Preventing Invasive Breast Cancer - Information from the NCI Press Office about this drug.

Find Clinical Trials for Raloxifene - Check for trials from NCI's list of cancer clinical trials now accepting patients.

Back to Top